Johns Hopkins All Children's Hospital

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Johns Hopkins All Children's Hospital sits in the top decile of US sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count).

24 total trials 4 currently recruiting 14 completed early-phase tilt top decile by trial count

Johns Hopkins All Children's Hospital: 24 sponsored US clinical trials, 4 recruiting.

Johns Hopkins All Children's Hospital sponsors 24 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 14 completed. 3 of these trials are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hemoglobinopathy (Disorder), with 1 trials.

Top-decile sponsor footprint

Johns Hopkins All Children's Hospital ranks in the top decile of sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 45/100

14 of 17 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

24 total, page 1 of 1

RECRUITING Phase 2

Azithromycin for Critical Asthma - Pediatrics

NCT06223828
RECRUITING NA

Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer

NCT06346782
RECRUITING Phase 2

TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

NCT04414046
RECRUITING Phase 2

TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

NCT04356469
ACTIVE NOT RECRUITING Phase 1

Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation

NCT03843528
NOT YET RECRUITING Phase 3

Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP).

NCT06628778
NOT YET RECRUITING Phase 2

Pediatric Asthma Trial of Corticosteroid Heterogeneity (PATCH): Trial of Dexamethasone Versus Methylprednisolone for Pediatric Critical Asthma

NCT07455396
COMPLETED Phase 2

Antibiotic Instillation in Appendicitis

NCT05470517
COMPLETED NA

Pilot Evaluation of a Motivational Interviewing Intervention Targeting Adherence Behaviors in Youth With Sickle Cell Disease

NCT04877054
COMPLETED NA

Duodenal Feeds in Very Low Birth Weight Infants

NCT04246333
COMPLETED NA

Pilot Evaluation of a Healthy Lifestyle Intervention for Adolescent and Young Adult Survivors of Pediatric Cancer

NCT04839952
COMPLETED Phase 2

COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial

NCT04354155
COMPLETED Phase 4

Ideal Steroids for Asthma Treatment in the PICU

NCT03900624
COMPLETED NA

Feasibility, Acceptability, and Fidelity of Motivational Interviewing to Increase Maternal NICU Presence

NCT06488196
TERMINATED Phase 2

Methadone Demonstration Project With Neonatal Intensive Care Unit Infants Diagnosed With Neonatal Abstinence Syndrome

NCT03134703
COMPLETED Phase 2

Safety, Efficacy, and Feasibility of High-dose Cholecalciferol in Pediatric Patients With Cystic Fibrosis

NCT02613884
TERMINATED Phase 1

Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors

NCT03050450
TERMINATED

Strata Programmable CSF Shunt Valve Study

NCT02737163
COMPLETED NA

Non-invasive Clinical Pectus Index as a Measurement of Severity in Pectus

NCT02552186
COMPLETED NA

Trans-incisional vs Laparoscopic Guided Rectus Sheath Block for Pediatric Single Incision Laparoscopic Cholecystectomy

NCT02494336
COMPLETED NA

Percutaneous Rectus Sheath Block Versus Intra-operative Rectus Sheath Block for Pediatric Umbilical Hernia Repair

NCT02341144
COMPLETED NA

Fast Track Appendectomy for Suppurative Appendicitis

NCT02137603
COMPLETED Phase 1

Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors

NCT00876993
COMPLETED Phase 3

Evaluation of the Duration of Therapy for Thrombosis in Children

NCT00687882

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 8
Phase 3 2
Phase 4 1

Therapeutic Areas

Hemoglobinopathy (Disorder) 1
Bone Marrow Failure Syndrome 1
Disruptive Behavior 1
Severe Aplastic Anemia 1
Primary Immune Deficiency Disorders 1
Pediatric Asthma 1
Mixed Phenotype Acute Leukemia 1
Juvenile Myelomonocytic Leukemia 1
Oncology 1
Critical Illness 1

What is open in the Johns Hopkins All Children's Hospital pipeline

4 recruiting of 24 indexed (17% open); 14 completed (58%).

Phase mix: 3 late (III/IV) vs 11 early (I/II) (early-phase heavy).

Top condition: Hemoglobinopathy (Disorder) (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Johns Hopkins All Children's Hospital: open-pipeline peers nationwide

Peers matched on 24 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

Johns Hopkins All Children's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 510152025 0%10%20%30% Total trials Recruiting share Johns Hopkins All Children's HospitalAcrotech BiopharmaAgenusAkebia TherapeuticsBlueprint Medicines CorporationAdageneAgendiaAkamis BioAngiodynamics
Johns Hopkins All Children's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Johns Hopkins All Children's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 24 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Johns Hopkins All Children's Hospital page

24 registered trials is a research-attention snapshot, not an endorsement of Johns Hopkins All Children's Hospital or any single study.

  • 4 of Johns Hopkins All Children's Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Hemoglobinopathy (Disorder) is the condition Johns Hopkins All Children's Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hemoglobinopathy (Disorder) trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Johns Hopkins All Children's Hospital pipeline card: 24 registered trials from official public datasets.Report a data error.